Bio Green Med Solution, Inc.(BGMS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $10.1M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BGMS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Bio Green Med Solution, Inc. (BGMS), a Healthcare sector company. BGMS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $10.1m in revenue. Based on the latest XBRL financial filings (Q1 2026), Bio Green Med Solution, Inc. reports quarterly revenue of $743.0K, net income of $-197.0K, free cash flow of $-279.0K. Top institutional holders of BGMS by reported 13-F value include RENAISSANCE TECHNOLOGIES, CITADEL ADVISORS, XTX Topco Ltd, based on the most recent SEC filings. BGMS trades on the Nasdaq exchange and files with the SEC under CIK 1130166. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BGMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bio Green Med Solution, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$743.0K
Net Income
Q1 2026
$-197.0K
Free Cash Flow
Q1 2026
$-279.0K
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
Net Income
+84.1% YoYOperating Income
+62.4% YoYEPS (Diluted)
-87062.2% YoYTotal Assets
-80.8% YoYOp. Cash Flow
+74.3% YoY| Metric | FY 2025 | FY 2021 | FY 2020 | FY 2018 | FY 2016 | FY 2014 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 -100.0% | $150.0K -82.2% | $843.0K -51.4% | $1.7M |
| Net Income | $-3.0M +84.1% | $-18.9M -123.6% | $-8.4M -15.9% | $-7.3M +38.2% | $-11.8M +39.2% | $-19.4M |
| Operating Income | $-8.4M +62.4% | $-22.4M -110.5% | $-10.6M -11.4% | $-9.5M +32.5% | $-14.2M +36.9% | $-22.4M |
| EPS (Diluted) | $-6.45 -87062.2% | $-0.01 +39.3% | $-0.01 | — | — | — |
| Total Assets | $8.2M -80.8% | $42.6M +15.7% | $36.8M +85.7% | $19.8M +0.8% | $19.7M -33.1% | $29.4M |
| Operating Cash Flow | $-4.8M +74.3% | $-18.5M -133.7% | $-7.9M -18.4% | $-6.7M | — | — |
Get alerted when BGMS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Bio Green Med Solution, Inc. including:
Top Institutional Holders of BGMS
RENAISSANCE TECHNOLOGIES LLC
$46.1K46,100 shCITADEL ADVISORS LLC
$22.1K22,051 shXTX Topco Ltd
$21.9K21,872 shGEODE CAPITAL MANAGEMENT, LLC
$21.6K21,588 shTower Research Capital LLC (TRC)
$4.3K4,261 shUBS Group AG
$2.2K2,169 shSBI Securities Co., Ltd.
$500.00500 shArcher Investment Corp
$1.001 shOSAIC HOLDINGS, INC.
$1.001 sh
| Fund | Value | Shares |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $46.1K | 46,100 |
| CITADEL ADVISORS LLC | $22.1K | 22,051 |
| XTX Topco Ltd | $21.9K | 21,872 |
| GEODE CAPITAL MANAGEMENT, LLC | $21.6K | 21,588 |
| Tower Research Capital LLC (TRC) | $4.3K | 4,261 |
| UBS Group AG | $2.2K | 2,169 |
| SBI Securities Co., Ltd. | $500.00 | 500 |
| Archer Investment Corp | $1.00 | 1 |
| OSAIC HOLDINGS, INC. | $1.00 | 1 |
More Healthcare Companies
View all Healthcare →Put BGMS on your watchlist
Track score changes the day Bio Green Med Solution, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BGMS a good stock to buy?
13F Pro's AI-powered analysis of Bio Green Med Solution, Inc. (BGMS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BGMS are available on the BGMS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own BGMS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BGMS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bio Green Med Solution, Inc.'s investment landscape.